- Home
- NSPR vs BTA Comparison
NSPR vs BTA Comparison
Compare NSPR & BTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- BTA
- Stock Information
- Founded
- NSPR 2005
- BTA 2006
- Country
- NSPR United States
- BTA United States
- Employees
- NSPR N/A
- BTA N/A
- Industry
- NSPR Medical/Dental Instruments
- BTA Trusts Except Educational Religious and Charitable
- Sector
- NSPR Health Care
- BTA Finance
- Exchange
- NSPR Nasdaq
- BTA Nasdaq
- Market Cap
- NSPR 101.8M
- BTA 119.9M
- IPO Year
- NSPR N/A
- BTA N/A
- Fundamental
- Price
- NSPR $2.38
- BTA $9.68
- Analyst Decision
- NSPR Strong Buy
- BTA
- Analyst Count
- NSPR 2
- BTA 0
- Target Price
- NSPR $4.50
- BTA N/A
- AVG Volume (30 Days)
- NSPR 79.2K
- BTA 21.9K
- Earning Date
- NSPR 11-11-2025
- BTA 01-01-0001
- Dividend Yield
- NSPR N/A
- BTA 5.22%
- EPS Growth
- NSPR N/A
- BTA N/A
- EPS
- NSPR N/A
- BTA N/A
- Revenue
- NSPR $7,066,000.00
- BTA N/A
- Revenue This Year
- NSPR $7.48
- BTA N/A
- Revenue Next Year
- NSPR $104.39
- BTA N/A
- P/E Ratio
- NSPR N/A
- BTA N/A
- Revenue Growth
- NSPR 7.60
- BTA N/A
- 52 Week Low
- NSPR $1.99
- BTA $8.59
- 52 Week High
- NSPR $3.80
- BTA $10.62
- Technical
- Relative Strength Index (RSI)
- NSPR 44.77
- BTA 86.69
- Support Level
- NSPR $2.35
- BTA $8.90
- Resistance Level
- NSPR $2.46
- BTA $8.99
- Average True Range (ATR)
- NSPR 0.08
- BTA 0.09
- MACD
- NSPR -0.00
- BTA 0.08
- Stochastic Oscillator
- NSPR 23.53
- BTA 95.71
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About BTA BlackRock Long-Term Municipal Advantage Trust of Beneficial Interest
Blackrock Long-term Municipal AdtgTrust is a diversified investment fund with an investment objective to provide current income exempt from regular U.S. federal income tax. The Fund invests more of its total assets in municipal bonds, municipal securities, and derivative instruments.